MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Nephros Cash Conversion Cycle 2011-2026 | NEPH
Annual Cash Conversion Cycle Nephros
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 | 246 | 373 | 547 | 175 | 244 | 32.5 | 23.3 | 49.4 | -409 | -345 | -839 | 183 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 547 | -839 | 33.9 |
Quarterly Cash Conversion Cycle Nephros
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129 | 133 | 131 | - | 191 | 160 | 151 | - | 134 | 153 | 156 | - | 231 | 275 | 347 | - | 351 | 439 | 411 | - | 556 | 732 | 328 | - | 145 | 197 | 218 | - | 198 | 272 | 179 | - | 36.2 | 36 | 76.1 | - | 74.5 | 69.6 | 60.7 | - | 113 | 63.9 | 42.5 | - | 20.4 | 22.8 | 22.4 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 732 | 20.4 | 190 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
262 | $ 20.95 | 1.21 % | $ 10.7 B | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 203.51 | -0.78 % | $ 58.5 B | USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
266 | $ 8.27 | 0.98 % | $ 167 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
134 | $ 79.9 | -0.91 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
143 | $ 151.28 | -0.24 % | $ 3.69 B | USA |
 |
AtriCure
ATRC
|
185 | $ 42.16 | -0.58 % | $ 1.98 B | USA |
 |
iRhythm Technologies
IRTC
|
58.7 | $ 187.98 | -0.67 % | $ 5.86 B | USA |
 |
electroCore
ECOR
|
2.97 | $ 5.1 | 1.39 % | $ 28.1 K | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 83.99 | -0.05 % | $ 4.23 B | USA |
 |
AngioDynamics
ANGO
|
124 | $ 10.01 | -0.4 % | $ 409 M | USA |
 |
Harvard Bioscience
HBIO
|
208 | $ 0.67 | 2.7 % | $ 28.4 M | USA |
 |
Repro Med Systems
KRMD
|
149 | $ 5.81 | -0.08 % | $ 265 M | USA |
 |
The Cooper Companies
COO
|
210 | $ 82.78 | -0.43 % | $ 16.5 B | USA |
 |
LeMaitre Vascular
LMAT
|
28.7 | $ 85.15 | 0.13 % | $ 1.91 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 137.3 | -0.44 % | $ 7.32 B | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 113.5 | -0.63 % | $ 5.5 B | USA |
 |
Merit Medical Systems
MMSI
|
171 | $ 89.12 | -4.36 % | $ 5.19 B | USA |
 |
InfuSystem Holdings
INFU
|
24.9 | $ 8.97 | 0.28 % | $ 185 M | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
208 | $ 587.36 | 0.39 % | $ 209 B | USA |
 |
Predictive Oncology
POAI
|
-241 | $ 7.04 | 4.15 % | $ 38.4 M | USA |
 |
Microbot Medical
MBOT
|
-52.9 | $ 2.17 | -1.14 % | $ 22.1 M |  Israel |
 |
Milestone Scientific
MLSS
|
545 | $ 0.29 | -0.75 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
79.4 | $ 23.54 | -0.28 % | $ 4.05 B | USA |
 |
OraSure Technologies
OSUR
|
167 | $ 2.65 | -0.38 % | $ 197 M | USA |
 |
Utah Medical Products
UTMD
|
280 | $ 59.13 | 0.69 % | $ 215 M | USA |
 |
Pro-Dex
PDEX
|
193 | $ 41.55 | 0.61 % | $ 137 M | USA |
 |
Pulse Biosciences
PLSE
|
36.5 | $ 15.08 | 2.41 % | $ 724 M | USA |
 |
Repligen Corporation
RGEN
|
272 | $ 167.44 | 0.61 % | $ 9.33 M | USA |
 |
ResMed
RMD
|
167 | $ 251.02 | 0.04 % | $ 36.7 B | USA |
 |
BioLife Solutions
BLFS
|
37.9 | $ 24.96 | 0.02 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
112 | $ 260.69 | - | $ 25.7 B | USA |
 |
Stereotaxis
STXS
|
212 | $ 2.58 | -0.19 % | $ 208 M | USA |
 |
Retractable Technologies
RVP
|
250 | $ 0.78 | - | $ 23.4 M | USA |
 |
STAAR Surgical Company
STAA
|
26 | $ 22.38 | -0.53 % | $ 1.1 B | USA |
 |
Teleflex Incorporated
TFX
|
183 | $ 110.92 | 0.83 % | $ 5.2 B | USA |
 |
West Pharmaceutical Services
WST
|
98.9 | $ 276.83 | 0.58 % | $ 20.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
63.9 | $ 12.45 | -0.36 % | $ 2.53 B | USA |